Alkermes(us:ALKS)

    29.67

    -0.13%

    Updated on 2024-12-23

    Open:29.63
    Close:29.67
    High:29.81
    Low:29.18
    Pre Close:29.71
    Volume:493746.00
    Amount:14.54M
    Turnover:0.31%
    Shares:161.80M
    MarketCap:4.80B

    About Alkermes Company

    Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

    Company Name: Alkermes
    Company Address: Connaught House,1 Burlington Road
    Employees: 2100
    Fiscar Year: 12-31
    IPO Date: 2011-09-19
    CIK: 1520262

    View all SEC Filings

    About

    Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
    Address:Connaught House,1 Burlington Road

    Market Movers